Randa Tao, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Travel
    Ineligible company: 
    The Lynx Group
    Topic: 
    Travel expenses to attend the annual Cholangiocarcinoma Summit
    Date added: 
    07/21/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Helsinn
    Topic: 
    Honorarium for participation on a cholangiocarcinoma advisory board
    Date added: 
    07/21/2022
    Relationship end date: 
    10/29/2021
  • Type of financial relationship: 
    Other
    Ineligible company: 
    QED Therapeutics
    Topic: 
    Honorarium for participation on a cholangiocarcinoma advisory board
    Date added: 
    07/21/2022
    Relationship end date: 
    10/30/2020
Return to 2022 Cellular Therapy Conference – Translating recent evidence on cellular therapy to real world management of malignancies